Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis.
Paracchini L, Pesenti C, Delle Marchette M, Beltrame L, Bianchi T, Grassi T, Buda A, Landoni F, Ceppi L, Bosetti C, Paderno M, Adorni M, Vicini D, Perego P, Leone BE, D'Incalci M, Marchini S, Fruscio R. Paracchini L, et al. Among authors: adorni m. JAMA Netw Open. 2020 Jul 1;3(7):e207566. doi: 10.1001/jamanetworkopen.2020.7566. JAMA Netw Open. 2020. PMID: 32609349 Free PMC article.
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer.
Paracchini L, Beltrame L, Grassi T, Inglesi A, Fruscio R, Landoni F, Ippolito D, Delle Marchette M, Paderno M, Adorni M, Jaconi M, Romualdi C, D'Incalci M, Siravegna G, Marchini S. Paracchini L, et al. Among authors: adorni m. Clin Cancer Res. 2021 May 1;27(9):2549-2559. doi: 10.1158/1078-0432.CCR-20-3345. Epub 2020 Dec 15. Clin Cancer Res. 2021. PMID: 33323403
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer.
Benvenuto G, Todeschini P, Paracchini L, Calura E, Fruscio R, Romani C, Beltrame L, Martini P, Ravaggi A, Ceppi L, Sales G, Donati F, Perego P, Zanotti L, Ballabio S, Grassi T, Delle Marchette M, Tognon G, Sartori E, Adorni M, Odicino F, D'Incalci M, Bignotti E, Romualdi C, Marchini S. Benvenuto G, et al. Among authors: adorni m. Int J Cancer. 2020 Jul 15;147(2):565-574. doi: 10.1002/ijc.32935. Epub 2020 Mar 13. Int J Cancer. 2020. PMID: 32096871
Advanced low grade serous ovarian cancer: A retrospective analysis of surgical and chemotherapeutic management in two high volume oncological centers.
Di Lorenzo P, Conteduca V, Scarpi E, Adorni M, Multinu F, Garbi A, Betella I, Grassi T, Bianchi T, Di Martino G, Amadori A, Maniglio P, Strada I, Carinelli S, Jaconi M, Aletti G, Zanagnolo V, Maggioni A, Savelli L, De Giorgi U, Landoni F, Colombo N, Fruscio R. Di Lorenzo P, et al. Among authors: adorni m. Front Oncol. 2022 Sep 27;12:970918. doi: 10.3389/fonc.2022.970918. eCollection 2022. Front Oncol. 2022. PMID: 36237308 Free PMC article.
Role of 18 F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up.
Dolci C, Ceppi L, Guerra L, Crivellaro C, Lamanna M, Adorni M, Elisei F, Bonazzi CM, Sina F, Fruscio R, Messa C. Dolci C, et al. Among authors: adorni m. Int J Gynecol Cancer. 2019 Oct;29(8):1298-1303. doi: 10.1136/ijgc-2019-000586. Epub 2019 Jul 30. Int J Gynecol Cancer. 2019. PMID: 31366569
Correction to: The impact of low-volume metastasis on disease-free survival of women with early-stage cervical cancer.
Buda A, Casarin J, Mueller M, Fanfani F, Zapardiel I, Mereu L, Puppo A, De Ponti E, Adorni M, Ferrari D, Gasparri ML, Ghezzi F, Scambia G, Papadia A. Buda A, et al. Among authors: adorni m. J Cancer Res Clin Oncol. 2021 Jun;147(6):1607. doi: 10.1007/s00432-020-03464-8. J Cancer Res Clin Oncol. 2021. PMID: 33219857 No abstract available.
88 results